JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB182630

Anti-ADAM17 (phospho T735) antibody

4

(1 Review)

|

(9 Publications)

Rabbit Polyclonal ADAM17 phospho T735 antibody. Suitable for WB and reacts with Human samples. Cited in 9 publications. Immunogen corresponding to Synthetic Peptide within Human ADAM17 phospho T735 aa 700-750 conjugated to Keyhole Limpet Haemocyanin.

View Alternative Names

CD156b, CSVP, TACE, ADAM17, Disintegrin and metalloproteinase domain-containing protein 17, ADAM 17, Snake venom-like protease, TNF-alpha convertase, TNF-alpha-converting enzyme

2 Images
Western blot - Anti-ADAM17 (phospho T735) antibody (AB182630)
  • WB

Supplier Data

Western blot - Anti-ADAM17 (phospho T735) antibody (AB182630)

All lanes:

Western blot - Anti-ADAM17 (phospho T735) antibody (ab182630) at 1/500 dilution

Lane 1:

Extracts from K562 cells treated with UV with Antigen specific peptide

Lane 2:

Extracts from K562 cells treated with UV

Predicted band size: 93 kDa,96 kDa

true

Western blot - Anti-ADAM17 (phospho T735) antibody (AB182630)
  • WB

CiteAb

Western blot - Anti-ADAM17 (phospho T735) antibody (AB182630)

ADAM17 (phospho T735) western blot using anti-ADAM17 (phospho T735) antibody ab182630. Publication image and figure legend from Huang, K. Y., Lin, M. S., et al., 2021, EMBO Mol Med, PubMed 33159417.

ab182630 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab182630 please see the product overview.

Functional characterization of the decoy antibodyCompetitive ELISA. ACE2-Fc can compete with ACE2-Fc-Biotin for Spike 1-674 binding in a dose-dependent manner. The competition effects of ACE2-Fc on ACE2-Spike protein binding were normalized to PBS control. Error bars represent the standard deviation (SD), n = 2. Statistical analysis was performed by unpaired two-tail t-test. **p < 0.01, ***p < 0.001.Recognition of full-length Spike on H1975 (left panel as negative control) or H1975-Spike (right panel) cells by ACE2-Fc using flow cytometry analysis. Isotype control : 40 μg/ml mouse IgG-FITC.Confocal microscopy of H1975-Spike-overexpressing cells. Spikes on H1975 cells were stained with anti-Spike antibody and Alexa Fluor® 594-conjugated secondary antibody on ice for 1 h. After that, ACE2-Fc-FITC was incubated for another 1 h. Scale bars equal to 20 μm. DAPI was used as a nuclear counterstain.Preservation of ACE2-Fc peptidase activity. The peptidase activity of ACE2-Fc was measured by cleavage of the fluorescent peptide substrates.Inhibition of angiotensin II (Ang II)-induced TNF-α production by ACE2-Fc. Ang II was preincubated with indicated amounts of ACE2-Fc or IgG for 30 min. After that, the mixtures were added to RAW264.7 cells for 12 h. The concentration of TNF-α in the culture medium was determined by ELISA. Error bars represent the standard deviation (SD), n = 3. Statistical analysis was performed by unpaired two-tail t-test. *p < 0.05. The dotted line represents the mean value of TNF-α in control group.Inhibition of Ang II-induced ADAM17 (a disintegrin and metalloprotease 17) phosphorylation by ACE2-Fc. The protein extracts from (E) were immunoblotted with the indicated antibodies (left panel). β-actin served as the loading control. The signal intensity was normalized to cells only (right panel). Data are representative of three independent experiments, and the values are expressed as the mean ± SD (right panel). Error bars represent the standard deviation (SD), n = 2. Statistical analysis was performed by unpaired two-tail t-test. *p < 0.05. IgG represents the human normal IgG control.

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

Synthetic Peptide within Human ADAM17 phospho T735 aa 700-750 conjugated to Keyhole Limpet Haemocyanin. The exact immunogen used to generate this antibody is proprietary information.

P78536

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/1000", "WB-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
Non-phospho specific antibodies were removed by chromatography using non-phosphopeptide.
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.88% Sodium chloride
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

ADAM17 also known as TACE (tumor necrosis factor-alpha converting enzyme) is a metalloprotease belonging to the ADAM (a disintegrin and metalloprotease) family. This protein functions by cleaving and shedding extracellular portions of cell surface proteins. It weighs approximately 93 kDa. ADAM17 is expressed in a range of tissues including the heart liver kidney and brain. The protein plays a role in the regulation of various biological processes through the activation and inactivation of membrane-bound precursor proteins.
Biological function summary

The ADAM17 protein regulates a multitude of cellular responses such as inflammation and growth factor signaling. It is not part of a complex but interacts with various substrates in the cell membrane. ADAM17 cleaves precursors to release soluble cytokines and growth factors like tumor necrosis factor-alpha (TNF-alpha) and epidermal growth factor receptor (EGFR) ligands which modulate cell proliferation migration and apoptosis.

Pathways

ADAM17 plays an integral role in both the TNF and EGFR signaling pathways. These pathways are important in maintaining normal cellular homeostasis. ADAM17 interacts with proteins like TNF receptors and ligands of the EGFR family integrating signaling that affects immune response and cell growth. The regulatory function of ADAM17 in these pathways makes it an important target for modulating cellular responses triggered by external stimuli.

ADAM17 has significant implications in conditions such as rheumatoid arthritis and cancer. In rheumatoid arthritis the protein's shedding activity influences inflammatory cytokines contributing to the disease’s pathogenesis alongside proteins like TNF-alpha. In cancer ADAM17's ability to release EGFR ligands affects tumor cell proliferation and metastasis with interactions involving EGFR proteins. It is a target of therapeutic interest with research focused on developing inhibitors to manage these diseases effectively.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Transmembrane metalloprotease which mediates the ectodomain shedding of a myriad of transmembrane proteins including adhesion proteins, growth factor precursors and cytokines important for inflammation and immunity (PubMed : 24226769, PubMed : 24227843, PubMed : 28060820, PubMed : 28923481). Cleaves the membrane-bound precursor of TNF-alpha to its mature soluble form (PubMed : 36078095, PubMed : 9034191). Responsible for the proteolytical release of soluble JAM3 from endothelial cells surface (PubMed : 20592283). Responsible for the proteolytic release of several other cell-surface proteins, including p75 TNF-receptor, interleukin 1 receptor type II, p55 TNF-receptor, transforming growth factor-alpha, L-selectin, growth hormone receptor, MUC1 and the amyloid precursor protein (PubMed : 12441351). Acts as an activator of Notch pathway by mediating cleavage of Notch, generating the membrane-associated intermediate fragment called Notch extracellular truncation (NEXT) (PubMed : 24226769). Plays a role in the proteolytic processing of ACE2 (PubMed : 24227843). Plays a role in hemostasis through shedding of GP1BA, the platelet glycoprotein Ib alpha chain (By similarity). Mediates the proteolytic cleavage of LAG3, leading to release the secreted form of LAG3 (By similarity). Mediates the proteolytic cleavage of IL6R, leading to the release of secreted form of IL6R (PubMed : 26876177, PubMed : 28060820). Mediates the proteolytic cleavage and shedding of FCGR3A upon NK cell stimulation, a mechanism that allows for increased NK cell motility and detachment from opsonized target cells. Cleaves TREM2, resulting in shedding of the TREM2 ectodomain (PubMed : 28923481).
See full target information ADAM17 phospho T735

Publications (9)

Recent publications for all applications. Explore the full list and refine your search

Journal of biomedical research :1-14 PubMed40441854

2025

Remote neuromuscular electrical stimulation upregulates MDK to enhance macrophage efferocytosis LRP1 in wound healing.

Applications

Unspecified application

Species

Unspecified reactive species

Lijuan Zong,Chong Liu,Li Zhang,Xueyou Tao,Qingyan Tian,Xiaokai Zhou,Yu Wang,Na Shen,Jiaming Gong,Qingyuan Zhuang,Tong Wang,Wentao Liu,Ying Shen,Liang Hu

Cell death & disease 13:888 PubMed36270986

2022

HDAC6-dependent deacetylation of TAK1 enhances sIL-6R release to promote macrophage M2 polarization in colon cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Guangying Xu,Liling Niu,Youhui Wang,Guang Yang,Xingwu Zhu,Yuan Yao,Gang Zhao,Shaowei Wang,Hui Li

Molecular cancer 21:92 PubMed35366893

2022

Circular RNA MTCL1 promotes advanced laryngeal squamous cell carcinoma progression by inhibiting C1QBP ubiquitin degradation and mediating beta-catenin activation.

Applications

Unspecified application

Species

Unspecified reactive species

Zheng Wang,Anqi Sun,Aihui Yan,Jian Yao,Haibo Huang,Ziming Gao,Tao Han,Jia Gu,Ni Li,Huizhe Wu,Kai Li

Theranostics 11:4770-4789 PubMed33754027

2021

Vertebral-specific activation of the CX3CL1/ICAM-1 signaling network mediates non-small-cell lung cancer spinal metastasis by engaging tumor cell-vertebral bone marrow endothelial cell interactions.

Applications

Unspecified application

Species

Unspecified reactive species

Ketao Wang,Libo Jiang,Annan Hu,Chi Sun,Lei Zhou,Yiwei Huang,Qing Chen,Jian Dong,Xiaogang Zhou,Feng Zhang

EMBO molecular medicine 13:e12828 PubMed33159417

2020

Humanized COVID-19 decoy antibody effectively blocks viral entry and prevents SARS-CoV-2 infection.

Applications

Unspecified application

Species

Unspecified reactive species

Kuo-Yen Huang,Ming-Shiu Lin,Ting-Chun Kuo,Ci-Ling Chen,Chung-Chih Lin,Yu-Chi Chou,Tai-Ling Chao,Yu-Hao Pang,Han-Chieh Kao,Rih-Sheng Huang,Steven Lin,Sui-Yuan Chang,Pan-Chyr Yang

International journal of oncology 57:249-263 PubMed32319605

2020

ADAM17-regulated CX3CL1 expression produced by bone marrow endothelial cells promotes spinal metastasis from hepatocellular carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Chi Sun,Annan Hu,Shengxing Wang,Bo Tian,Libo Jiang,Yun Liang,Houlei Wang,Jian Dong

The Journal of biological chemistry 295:7168-7177 PubMed32241917

2020

A JUN N-terminal kinase inhibitor induces ectodomain shedding of the cancer-associated membrane protease Prss14/epithin via protein kinase CβII.

Applications

Unspecified application

Species

Unspecified reactive species

Joobyoung Yoon,Youngkyung Cho,Ki Yeon Kim,Min Ji Yoon,Hyo Seon Lee,Sangjun Davie Jeon,Yongcheol Cho,Chungho Kim,Moon Gyo Kim

Phytotherapy research : PTR 34:1096-1107 PubMed32197276

2020

Astragaloside III activates TACE/ADAM17-dependent anti-inflammatory and growth factor signaling in endothelial cells in a p38-dependent fashion.

Applications

Unspecified application

Species

Unspecified reactive species

Haifang Wang,Ruihua Yuan,Qingwen Cao,Mian Wang,Dezhi Ren,Xiaoyan Huang,Min Wu,Linping Zhang,Xiangrong Zhao,Xueping Huo,Yalei Pan,Qinshe Liu

Phytotherapy research : PTR 30:790-6 PubMed26806653

2016

Hydroxy-Safflower Yellow A inhibits the TNFR1-Mediated Classical NF-κB Pathway by Inducing Shedding of TNFR1.

Applications

Unspecified application

Species

Unspecified reactive species

Haifang Wang,Jinlian Liu,Yuejin Yang,Qingwen Cao,Xueping Huo,Shuhui Ma,Jun Hu,Fredrick M Pavalko,Qinshe Liu
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com